T-cell-mediated disruption of the neuronal microtubule network: Correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis

American Journal of Pathology

Volumn 169, Issue 3, 2006, Pages 999-1011

  Shriver, Leah P ^b   Dittel, Bonnie N ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; THY 1 ANTIGEN; YELLOW FLUORESCENT PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; DISEASE COURSE; IN VITRO STUDY; MOUSE; NERVE CELL; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; T LYMPHOCYTE;

EID: 33748784089     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050791     Document Type: Article

References (44)

1. Lassmann H: Axonal injury in multiple sclerosis. J Neurol Neurosurg Psychiatry 2003, 74:695-697
2. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000, 343:938-952
3. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H: Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 2000, 157:267-276
4. Medana IM, Esiri MM: Axonal damage: a key predictor of outcome in human CNS diseases. Brain 2003, 126:515-530
5. Bjartmar C, Wujek JR, Trapp BD: Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 2003, 206:165-171
6. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Brück W: Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002, 125:2202-2212
7. Parry A, Corkill R, Blamire AM, Palace J, Narayanan S, Arnold D, Styles P, Matthews PM: Beta-interferon treatment does not always slow the progression of axonal injury in multiple sclerosis. J Neurol 2003, 250:171-178
8. Tsunoda I, Kuang LQ, Libbey JE, Fujinami RS: Axonal injury heralds virus-induced demyelination. Am J Pathol 2003, 162:1259-1269
9. Umehara F, Abe M, Koreeda Y, Izumo S, Osame M: Axonal damage revealed by accumulation of β-amyloid precursor protein in HTLV-I-associated myelopathy. J Neurol Sci 2000, 176:95-101
10. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bö L: Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278-285
11. Mori I, Goshima F, Mizuno T, Imai Y, Kohsaka S, Ito H, Koide N, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y: Axonal injury in experimental herpes simplex encephalitis. Brain Res 2005, 1057:186-190
12. S mice. J Neurol Sci 2005, 233:133-138
13. Petzold A: Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 2005, 233:183-198
14. Guzik BW, Goldstein LS: Microtubule-dependent transport in neurons: steps towards an understanding of regulation, function and dysfunction. Curr Opin Cell Biol 2004, 16:443-450
15. Hirokawa N, Takemura R: Molecular motors in neuronal development, intracellular transport and diseases. Curr Opin Neurobiol 2004, 14:564-573
16. Hirokawa N, Takemura R: Molecular motors and mechanisms of directional transport in neurons. Nat Rev Neurosci 2005, 6:201-214
17. Trushina E, Dyer RB, Badger II JD, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V, McPherson PS, Mandavilli BS, Van Houten B, Zeitlin S, McNiven M, Aebersold R, Hayden M, Parisi JE, Seeberg E, Dragatsis I, Doyle K, Bender A, Chacko C, McMurray CT: Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 2004, 24:8195-8209
18. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR: Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 2000, 28:41-51
19. Dittel BN, Merchant RM, Janeway Jr CA: Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 1999, 162:6392-6400
20. Ransom BR, Neale E, Henkart M, Bullock PN, Nelson PG: Mouse spinal cord in cell culture. I. Morphology and intrinsic neuronal electrophysiologic properties. J Neurophysiol 1977, 40:1132-1150
21. Ponomarev ED, Dittel BN: γδ T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism. J Immunol 2005, 174:4678-4687
22. Ponomarev ED, Shriver LP, Maresz K, Dittel BN: Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 2005, 81:374-389
23. Prineas JW, Connell F: Remyelination in multiple sclerosis. Ann Neurol 1979, 5:22-31
24. Coleman M: Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005, 6:889-898
25. Bannerman PG, Hahn A, Ramirez S, Morley M, Bönnemann C, Yu S, Zhang GX, Rostami A, Pleasure D: Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice. Brain 2005, 128:1877-1886
26. Brendza RP, Bacskai BJ, Cirrito JR, Simmons KA, Skoch JM, Klunk WE, Mathis CA, Bales KR, Paul SM, Hyman BT, Holtzman DM: Anti-Aβ antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. J Clin Invest 2005, 115:428-433
27. Nguyen QT, Sanes JR, Lichtman JW: Pre-existing pathways promote precise projection patterns. Nat Neurosci 2002, 5:861-867
28. 2+ exchanger. Proc Natl Acad Sci USA 2004, 101:8168-8173
29. Nicot A, Ratnakar PV, Ron Y, Chen CC, Elkabes S: Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain 2003, 126:398-412
30. Zhu B, Luo L, Moore GR, Paty DW, Cynader MS: Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am J Pathol 2003, 162:1639-1650
31. Hanak SE, Reilly EM, Wotanis J, Zhu B, Pulicicchio C, McMonagle-Strucko K, Wettstein JG, Black MD: An electrophysiological model of spinal transmission deficits in mouse experimental autoimmune encephalomyelitis. J Pharmacol Exp Ther 2004, 308:214-220
32. Compston A: The pathogenesis and basis for treatment in multiple sclerosis. Clin Neurol Neurosurg 2004, 106:246-248
33. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, Montague P, Barrie JA, McCulloch MC, Duncan ID, Garbern J, Nave KA, Griffiths IR: Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 2004, 166:121-131
34. Linker RA, Sendtner M, Gold R: Mechanisms of axonal degeneration in EAE-lessons from CNTF and MHC I knockout mice. J Neurol Sci 2005, 233:167-172
35. Anderson TJ, Schneider A, Barrie JA, Klugmann M, McCulloch MC, Kirkham D, Kyriakides E, Nave KA, Griffiths IR: Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. J Comp Neurol 1998, 394:506-519
36. Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Makriyannis A, Khanolkar A, Layward L, Fezza F, Bisogno T, Di Marzo V: Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J 2001, 15:300-302
37. Pender MP, Nguyen KB, Willenborg DO: Demyelination and early remyelination in experimental allergic encephalomyelitis passively transferred with myelin basic protein-sensitized lymphocytes in the Lewis rat. J Neuroimmunol 1989, 25:125-142
38. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W: Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000, 123:1174-1183
39. Ransohoff RM, Trapp BD: Taking two TRAILS. Neuron 2005, 46:355-356
40. Kim IJ, Beck HN, Lein PJ, Higgins D: Interferon γ induces retrograde dendritic retraction and inhibits synapse formation. J Neurosci 2002, 22:4530-4539
41. Giuliani F, Goodyer CG, Antel JP, Yong VW: Vulnerability of human neurons to T cell-mediated cytotoxicity. J Immunol 2003, 171:368-379
42. Medana I, Martinic MA, Wekerle H, Neumann H: Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol 2001, 159:809-815
43. Aktas O, Smorodchenko A, Bracke S, Infante-Duarte C, Topphoff US, Vogt J, Prozorovski T, Meier S, Osmanova V, Pohl E, Bechmann I, Nitsch R, Zipp F: Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron 2005, 46:421-432
44. Stagi M, Dittrich PS, Frank N, Iliev AI, Schwille P, Neumann H: Breakdown of axonal synaptic vesicle precursor transport by microglial nitric oxide. J Neurosci 2005, 25:352-362